David D Celentano
Overview
Explore the profile of David D Celentano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
273
Citations
6842
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McFall A, Gunaratne M, Ganapathi L, Srikrishnan A, Vasudevan C, Anand S, et al.
J Int AIDS Soc
. 2024 Sep;
27(9):e26361.
PMID: 39301675
Introduction: Globally, there have been significant declines in HIV incidence over the past two decades, but this decline is slowing, and in some settings, declines have stalled or are growing-particularly...
2.
Solomon S, McFall A, Srikrishnan A, Verma V, Anand S, Khan R, et al.
Lancet HIV
. 2024 Apr;
11(5):e309-e320.
PMID: 38583461
Background: Progress on HIV treatment outcomes for people who inject drugs and men who have sex with men in India has been slow compared with that in other populations. We...
3.
Leucker T, Harb T, Gerstenblith G, Celentano D, Ziogos E, Treisman G, et al.
Int J STD AIDS
. 2024 Mar;
35(8):600-607.
PMID: 38531830
Background And Aims: People with HIV (PWH) whose disease is controlled on anti-retroviral regimens remain at an increased risk for coronary artery disease (CAD). Traditional cardiovascular risk factors do not...
4.
Iqbal H, Gunaratne M, Loeb T, Pradeep A, McFall A, Srikrishnan A, et al.
J Viral Hepat
. 2024 Feb;
31(5):271-274.
PMID: 38385866
People living with HIV (PWH) have been shown to bear a higher burden of hepatitis B virus (HBV) due to shared routes and risk factors for transmission. Populations such as...
5.
Lai H, Treisman G, Celentano D, Gerstenblith G, Mandler R, Khalsa J, et al.
Int J STD AIDS
. 2023 Dec;
35(4):296-307.
PMID: 38065684
In the antiretroviral therapy (ART) era, HIV-associated neurocognitive disorders (HAND) remain a considerable challenge for people with HIV, yet not all such disorders can be attributed to HIV alone. This...
6.
Sabri B, Budhathoki C, McFall A, Mehta S, Celentano D, Solomon S, et al.
PLoS One
. 2023 Dec;
18(12):e0295225.
PMID: 38039322
Lifetime exposures to violence among men who have sex with men (MSM) are associated with multiple psychosocial health risks and can affect engagement and outcomes of HIV treatment. This study...
7.
Karver T, Barrington C, Donastorg Y, Perez M, Gomez H, Page K, et al.
PLOS Glob Public Health
. 2023 Apr;
3(4):e0001479.
PMID: 37115734
Despite increased attention and efforts to improve HIV care among female sex workers (FSWs), they continue to have suboptimal HIV outcomes. Exploring the socio-structural dynamics related to the quality of...
8.
Lai H, Celentano D, Treisman G, Khalsa J, Gerstenblith G, Page B, et al.
AIDS Patient Care STDS
. 2023 Apr;
37(5):243-252.
PMID: 37083446
HIV-associated neurocognitive disorders (HAND) remain a major challenge for people with HIV in the antiretroviral therapy era. Cocaine use may trigger/exacerbate HAND among African American (AA) adults, especially women. Between...
9.
10.
Clipman S, Solomon S, Srikrishnan A, McFall A, Gomathi S, Saravanan S, et al.
Open Forum Infect Dis
. 2022 Oct;
9(10):ofac481.
PMID: 36225747
Background: Drug resistance testing is limited in public-sector human immunodeficiency virus (HIV) care in India, and there are few systematic samplings for prevalent drug resistance mutations (DRMs), particularly among men...